Dr. Jean-Luc Harousseau provides an update on trials Velcade with pegolated doxirubucin in multiple myeloma at the 2007 ASCO meeting. For more information, contact the International Myeloma Foundation, http://www.myeloma.org, theimf@myeloma.org, 800-452-2873 or 818-487-7455
Link to this comment:
All Comments (0)